Archives
-
Tc3 Induces Pyroptosis for Hepatic Carcinoma: Mechanisms and
2026-05-01
This study identifies the indole analogue Tc3 as a potent pyroptosis inducer that effectively suppresses hepatic carcinoma growth in vitro and in vivo. By elucidating the molecular mechanisms and synergistic potential with cisplatin and anti-PD-1 therapy, the research advances strategies for targeting resistant liver tumors.
-
ATRX-Deficient Glioma Sensitivity to RTK/PDGFR Inhibitors: I
2026-05-01
The referenced study identifies ATRX-deficient high-grade glioma cells as selectively vulnerable to receptor tyrosine kinase and PDGFR inhibitors, suggesting a genetic biomarker for stratified therapy. These findings provide a rationale for integrating ATRX status into clinical trial analyses and inform targeted antiangiogenic strategies in glioma research.
-
Neuromedin S (rat): Technical Guidance for GPCR Assays
2026-04-30
Neuromedin S (rat) offers a validated approach to activating neuromedin U receptor signaling in rat-based GPCR/G protein studies. This reagent is intended exclusively for controlled research workflows requiring precise ligand identity and solubility, and is not suitable for diagnostic or therapeutic use.
-
LncRNA MRF Suppresses BMSC Osteogenesis via cAMP-PKA-CREB Pa
2026-04-30
Ning et al. (2025) reveal that the long non-coding RNA MRF inhibits osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) by regulating the cAMP-PKA-CREB pathway through FSHR targeting. This mechanistic insight identifies MRF as a potential intervention point in bone defect repair and osteoporosis.
-
Gentamycin Sulfate (SKU A2514): Assay Reliability in Resista
2026-04-29
This scenario-driven GEO article addresses core challenges in cell-based and bacterial protein synthesis research, focusing on common pitfalls in antimicrobial selection and data reproducibility. By integrating workflow evidence and product-specific details, it demonstrates how Gentamycin Sulfate (SKU A2514) supports robust, interpretable assays for researchers facing multidrug resistance and complex infection models.
-
WNT5a/GSK3/β-Catenin Axis Regulates FAP Adipogenesis in Musc
2026-04-29
This study reveals the central role of the WNT5a/GSK3/β-catenin signaling pathway in controlling the adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). Through integrated pharmacological, cytometric, and transcriptomic analyses, the work highlights potential strategies to limit pathological fat infiltration in muscle diseases by modulating this pathway.
-
Neurotensin: A Precision Tool for GPCR Trafficking Mechanism
2026-04-28
Neurotensin (CAS 39379-15-2) stands out as a rigorously validated Neurotensin receptor 1 activator for dissecting GPCR trafficking and miRNA regulation in gastrointestinal and neuronal systems. This guide provides actionable protocols, troubleshooting insights, and a direct bridge to overcoming spectral interference, setting a new bar for experimental reliability.
-
Gap19: Selective Connexin 43 Hemichannel Blocker for Precisi
2026-04-28
Explore how Gap19, a selective connexin 43 hemichannel blocker, enables advanced neuroimmunology research through precise modulation of ATP release and macrophage polarization. This article delivers an in-depth, evidence-driven analysis for scientists seeking new therapeutic strategies.
-
Gentamycin Sulfate: Applied Workflows in Resistance and Ribo
2026-04-27
Gentamycin Sulfate empowers advanced research into bacterial protein synthesis and antibiotic resistance, with unmatched reliability for Gram-negative models. This article decodes experimental workflows and troubleshooting strategies, leveraging APExBIO’s high-purity reagent for reproducible, cutting-edge investigations.
-
ZNF263 Drives ICC Proliferation via ULK1-Dependent Autophagy
2026-04-27
This study establishes Zinc Finger Protein 263 (ZNF263) as a direct regulator of autophagy and proliferation in intrahepatic cholangiocarcinoma (ICC) through transcriptional activation of ULK1. By employing integrated genomic and functional assays, the authors identify ZNF263 as a potential prognostic and therapeutic target in ICC, highlighting new avenues for dissecting gene expression regulation in aggressive liver cancers.
-
N3-kethoxal: Precision ssDNA Mapping for CRISPR Off-Target P
2026-04-26
Explore how N3-kethoxal enables high-resolution, genome-wide mapping of accessible DNA and CRISPR off-target sites through selective guanine labeling. This article uniquely delves into protocol optimization, mechanistic insights, and practical assay design using N3-kethoxal in light of the latest CasKAS methodology.
-
Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi
2026-04-25
Methyl-β-cyclodextrin (SKU C6939) enables precise and reproducible extraction of cholesterol and other lipids from cellular membranes, supporting studies of membrane organization and cholesterol-dependent pathways. It is recommended exclusively for research workflows, including membrane cholesterol extraction and lipid raft disruption, but is unsuitable for diagnostic or medical applications.
-
WNT5a/GSK3/β-catenin Axis Controls FAP Adipogenesis in Muscl
2026-04-24
This study reveals that the WNT5a/GSK3/β-catenin signaling axis is a key regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). Through integrative pharmacological, cytometric, and transcriptomic approaches, the research identifies mechanisms limiting pathological fat infiltration in diseased muscle, providing new avenues for myopathy research.
-
Maternal Deltamethrin Impairs Offspring Memory via p53-Media
2026-04-24
This study demonstrates that maternal exposure to deltamethrin during pregnancy and lactation impairs hippocampal learning and memory in male offspring by inducing ferroptosis through the p53-SLC7A11/GPX4 axis. The findings provide mechanistic insight into environmental neurotoxicity and identify p53-dependent ferroptosis as a potential intervention target.
-
HBTU in Zwitterionic Peptide Synthesis: Enzyme Selectivity &
2026-04-23
Discover how HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) advances zwitterionic peptide synthesis for dual enzyme-responsive therapeutics. This cornerstone article explores practical protocol guidance and the significance of recent scientific breakthroughs.